Skip to the page

Data / Drug companies / Cabinet Health P.B.C.

Cabinet Health P.B.C.: 43 products in the FDA NDC directory, labeler code 82725

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Cabinet Health P.B.C. (labeler code 82725) lists 43 products in the FDA National Drug Code Directory, covering 17 finished drugs by generic name. By type: 42 over the counter drugs, 1 drugs for further processing. Its main marketing category is over the counter monograph drugs. The newest product started marketing on October 5, 2026.

The request: Watch Cabinet Health P.B.C. (FDA labeler code 82725): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
82725
Products in commercial distribution
43
Packages
64
Finished drugs by generic name
17
Prescription products
0
Over the counter products
42
Flagged as original packager
33 of 33 products that carry the flag
Started marketing in the last 12 months
20
Products with a marketing end date set
1
Earliest marketing start
October 1, 2024
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Over the counter monograph drugs2148.8%
Generic drugs (ANDA)2046.5%
Drugs for further processing24.7%

Products by type

TypeProductsShare
Over the counter drugs4297.7%
Drugs for further processing12.3%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

Dosage forms

Dosage formProductsShare
Tablet3683.7%
Capsule, liquid filled49.3%
Capsule, delayed release12.3%
Capsule, gelatin coated12.3%
Tablet, delayed release12.3%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
GoodMeds Nighttime Cold and Flu82725-4106Capsule, liquid filledOver the counter monograph drugsOctober 5, 2026
GoodMeds Daytime Cold and Flu82725-4105Capsule, liquid filledOver the counter monograph drugsOctober 5, 2026
GoodMeds Cetirizine 10mg82725-4203TabletGeneric drugs (ANDA)October 1, 2026
ValuMeds Cetirizine 10mg82725-1203TabletGeneric drugs (ANDA)October 1, 2026
GoodMeds Ibuprofen 200mg82725-4029TabletGeneric drugs (ANDA)September 14, 2026
GoodMeds Acid Reducer 24HR Esomeprazole Magnesium Delayed-Release 20mg82725-4053Capsule, delayed releaseGeneric drugs (ANDA)August 17, 2026
GoodMeds 24HR Acid Reducer Omeprazole 20mg82725-4052Tablet, delayed releaseGeneric drugs (ANDA)August 17, 2026
Goodmeds extra strength pain relief acetaminophen82725-4027TabletOver the counter monograph drugsJuly 9, 2026
Goodmeds Famotidine 20mg 500 count82725-4047TabletGeneric drugs (ANDA)July 3, 2026
GoodMeds Nasal Decongestant82725-4011TabletOver the counter monograph drugsJuly 1, 2026
Goodmeds Levocetirizine Dihydrochloride 5mg 365 count82725-4051TabletGeneric drugs (ANDA)June 30, 2026
ValuMeds Nasal Decongestant PE Phenylephrine82725-1011TabletOver the counter monograph drugsJune 1, 2026
Goodmeds Non-Drowsy Nasal Decongestant PE82725-4111TabletOver the counter monograph drugsMay 15, 2026
Goodmeds Allergy Relief82725-4201TabletOver the counter monograph drugsMay 10, 2026
Goodmeds Allergy Relief Diphenhydramine HCl82725-4001TabletOver the counter monograph drugsApril 15, 2026
Goodmeds all day allergy relief cetirizine hcl82725-4103TabletGeneric drugs (ANDA)April 10, 2026
Goodmeds Non Drowsy Allergy Relief82725-4202TabletGeneric drugs (ANDA)February 10, 2026
Goodmeds cough relief dextromethorphan hbr82725-4110Capsule, gelatin coatedOver the counter monograph drugsFebruary 1, 2026
Goodmeds Allergy Relief Diphenhydramine HCl82725-4101TabletOver the counter monograph drugsFebruary 1, 2026
Goodmeds Extra Strength Pain Relief PM82725-4124TabletOver the counter monograph drugsNovember 11, 2025
Valumeds non-drowsy allergy relief fexofenadine hcl82725-1202TabletGeneric drugs (ANDA)November 1, 2025
Fexofenadine hydrochloride82725-0102TabletDrugs for further processingOctober 25, 2025
Goodmeds Non-Drowsy Cough Relief82725-4010Capsule, liquid filledOver the counter monograph drugsOctober 10, 2025
ValuMeds Allergy Relief Loratadine82725-1142TabletGeneric drugs (ANDA)October 1, 2025
Loratadine82725-0142TabletGeneric drugs (ANDA)October 1, 2025

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.